These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1010 related articles for article (PubMed ID: 35224730)

  • 1. Antiplatelet agents for chronic kidney disease.
    Natale P; Palmer SC; Saglimbene VM; Ruospo M; Razavian M; Craig JC; Jardine MJ; Webster AC; Strippoli GF
    Cochrane Database Syst Rev; 2022 Feb; 2(2):CD008834. PubMed ID: 35224730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphate binders for preventing and treating chronic kidney disease-mineral and bone disorder (CKD-MBD).
    Ruospo M; Palmer SC; Natale P; Craig JC; Vecchio M; Elder GJ; Strippoli GF
    Cochrane Database Syst Rev; 2018 Aug; 8(8):CD006023. PubMed ID: 30132304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiplatelet agents for chronic kidney disease.
    Palmer SC; Di Micco L; Razavian M; Craig JC; Perkovic V; Pellegrini F; Jardine MJ; Webster AC; Zoungas S; Strippoli GF
    Cochrane Database Syst Rev; 2013 Feb; (2):CD008834. PubMed ID: 23450589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis.
    Tunnicliffe DJ; Palmer SC; Cashmore BA; Saglimbene VM; Krishnasamy R; Lambert K; Johnson DW; Craig JC; Strippoli GF
    Cochrane Database Syst Rev; 2023 Nov; 11(11):CD007784. PubMed ID: 38018702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sodium-glucose co-transporter protein 2 (SGLT2) inhibitors for people with chronic kidney disease and diabetes.
    Natale P; Tunnicliffe DJ; Toyama T; Palmer SC; Saglimbene VM; Ruospo M; Gargano L; Stallone G; Gesualdo L; Strippoli GF
    Cochrane Database Syst Rev; 2024 May; 5(5):CD015588. PubMed ID: 38770818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antioxidants for adults with chronic kidney disease.
    Colombijn JM; Hooft L; Jun M; Webster AC; Bots ML; Verhaar MC; Vernooij RW
    Cochrane Database Syst Rev; 2023 Nov; 11(11):CD008176. PubMed ID: 37916745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calcium channel blockers for people with chronic kidney disease requiring dialysis.
    Mugendi GA; Mutua FM; Natale P; Esterhuizen TM; Strippoli GF
    Cochrane Database Syst Rev; 2020 Oct; 10(10):CD011064. PubMed ID: 33000470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Omega-3 fatty acids for dialysis vascular access outcomes in patients with chronic kidney disease.
    Tam KW; Wu MY; Siddiqui FJ; Chan ES; Zhu Y; Jafar TH
    Cochrane Database Syst Rev; 2018 Nov; 11(11):CD011353. PubMed ID: 30480758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aldosterone antagonists in addition to renin angiotensin system antagonists for preventing the progression of chronic kidney disease.
    Chung EY; Ruospo M; Natale P; Bolignano D; Navaneethan SD; Palmer SC; Strippoli GF
    Cochrane Database Syst Rev; 2020 Oct; 10(10):CD007004. PubMed ID: 33107592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for adults with early (stage 1 to 3) non-diabetic chronic kidney disease.
    Cooper TE; Teng C; Tunnicliffe DJ; Cashmore BA; Strippoli GF
    Cochrane Database Syst Rev; 2023 Jul; 7(7):CD007751. PubMed ID: 37466151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psychosocial interventions for preventing and treating depression in dialysis patients.
    Natale P; Palmer SC; Ruospo M; Saglimbene VM; Rabindranath KS; Strippoli GF
    Cochrane Database Syst Rev; 2019 Dec; 12(12):CD004542. PubMed ID: 31789430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peritoneal dialysis versus haemodialysis for people commencing dialysis.
    Ethier I; Hayat A; Pei J; Hawley CM; Johnson DW; Francis RS; Wong G; Craig JC; Viecelli AK; Htay H; Ng S; Leibowitz S; Cho Y
    Cochrane Database Syst Rev; 2024 Jun; 6(6):CD013800. PubMed ID: 38899545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antihypertensive treatment for kidney transplant recipients.
    Natale P; Mooi PK; Palmer SC; Cross NB; Cooper TE; Webster AC; Masson P; Craig JC; Strippoli GF
    Cochrane Database Syst Rev; 2024 Jul; 7(7):CD003598. PubMed ID: 39082471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological interventions for heart failure in people with chronic kidney disease.
    Lunney M; Ruospo M; Natale P; Quinn RR; Ronksley PE; Konstantinidis I; Palmer SC; Tonelli M; Strippoli GF; Ravani P
    Cochrane Database Syst Rev; 2020 Feb; 2(2):CD012466. PubMed ID: 32103487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Home versus in-centre haemodialysis for people with kidney failure.
    Cheetham MS; Ethier I; Krishnasamy R; Cho Y; Palmer SC; Johnson DW; Craig JC; Stroumza P; Frantzen L; Hegbrant J; Strippoli GF
    Cochrane Database Syst Rev; 2024 Apr; 4(4):CD009535. PubMed ID: 38588450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin and glucose-lowering agents for treating people with diabetes and chronic kidney disease.
    Lo C; Toyama T; Wang Y; Lin J; Hirakawa Y; Jun M; Cass A; Hawley CM; Pilmore H; Badve SV; Perkovic V; Zoungas S
    Cochrane Database Syst Rev; 2018 Sep; 9(9):CD011798. PubMed ID: 30246878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low protein diets for non-diabetic adults with chronic kidney disease.
    Hahn D; Hodson EM; Fouque D
    Cochrane Database Syst Rev; 2020 Oct; 10(10):CD001892. PubMed ID: 33118160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low protein diets for non-diabetic adults with chronic kidney disease.
    Hahn D; Hodson EM; Fouque D
    Cochrane Database Syst Rev; 2018 Oct; 10(10):CD001892. PubMed ID: 30284724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potassium binders for chronic hyperkalaemia in people with chronic kidney disease.
    Natale P; Palmer SC; Ruospo M; Saglimbene VM; Strippoli GF
    Cochrane Database Syst Rev; 2020 Jun; 6(6):CD013165. PubMed ID: 32588430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 51.